Genome editing or most profoundly called gene editing is a set of advanced tools and technologies that are involved in the alteration of a particular DNA sequence. Genome editing lets the scientists indulge in adding, removing, or altering a particular gene/ genetic material at a précised location on the genome. The market has witnessed various types of approaches that fall under the umbrella of genome editing across the globe. These are Cas9 (CRISPR-associated protein 9), ZFNs (zinc-finger nucleases), CRISPR (clustered regularly interspaced short palindromic repeats), TALENs (transcription activator-like effector nucleases), and Antisense. A new addition to the list of technologies is the prime editing technology which was recently proposed i.e. in the early months of 2019. Famously called “search and replace” technology, prime editing is a genetic or DNA strand editing technology that can do gene base manipulation using the prime gene part of the DNA. Insertion, deletion, and base swapping are the major roles of this technology.
This report contains market size and forecasts of Prime Editing Technology in Global, including the following market information:
Global Prime Editing Technology Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Prime Editing Technology market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Gene Editing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prime Editing Technology include Beam Therapeutics, Inscripta, Precision BioSciences, Sangamo Therapeutics, Horizon Discovery, CRISPR Therapeutics, GenScript, Intellia Therapeutics and Synthego Corporation. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prime Editing Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prime Editing Technology Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Prime Editing Technology Market Segment Percentages, by Type, 2021 (%)
Gene Editing
Regulation of Genome
Gene-Modified Cell Therapy
Cell Line Engineering
Global Prime Editing Technology Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Prime Editing Technology Market Segment Percentages, by Application, 2021 (%)
Academic Institutions
Biotechnology and Pharma Companies
Contract Research Organizations
Others
Global Prime Editing Technology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Prime Editing Technology Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prime Editing Technology revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Prime Editing Technology revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Beam Therapeutics
Inscripta
Precision BioSciences
Sangamo Therapeutics
Horizon Discovery
CRISPR Therapeutics
GenScript
Intellia Therapeutics
Synthego Corporation